Mylan gets Kinney Drugs' antitrust claims over EpiPen dismissed
MLex Summary: Mylan has won the dismissal of Kinney Drugs’ antitrust claims over EpiPen. US District Judge Daniel D. Crabtree concluded that Kinney lacks standing as an indirect purchaser and its...To view the full article, register now.
Already a subscriber? Click here to view full article